US President Donald Trump has announced a phased tariff plan targeting imported generic medicines, a move that could have significant consequences for India’s pharmaceutical industry and its exports to the American market. Under the proposed policy, generic medicines entering the United States will continue to face zero tariffs for a two-year transition period beginning August...
